Temple University President John Fry announced today that Abhi Rastogi, MBA, MIS will succeed Michael A. Young, MHA, FACHE as President and Chief Executive Officer of Temple Health. This transition, as part of Young’s planned retirement, marks the culmination of a long and distinguished tenure. The leadership change will be executed on January 2, 2026, in accordance with Temple Health’s established succession plan. 

An alumnus of Temple’s Fox School of Business, Rastogi has spent more than 20 years with Temple Health, most recently as President and CEO of Temple University Hospital and Executive Vice President and Chief Operating Officer of Temple Health. Rastogi will continue to lead Temple University Hospital while serving as CEO of Temple Health.  

“Abhi is a Temple Made leader. This internal transition demonstrates stability, strength, and continuity of purpose at Temple Health,” said President Fry. “Abhi is highly respected within the Temple community, known for his passion, integrity, and shoulder-to-shoulder leadership style. Working with Mike Young and the entire Health System team, Abhi has played a vital role in meeting Temple Health’s mission and achieving sustainable growth.”  

“Abhi Rastogi is an exceptional leader with a deep understanding of Temple’s mission,” added Amy J. Goldberg, MD, FACS, Marjorie Joy Katz Dean, Lewis Katz School of Medicine at Temple University. “Bound by our Temple Made roots, we share a deep connection to this institution and its mission. I look forward to working alongside him to strengthen Temple’s role as a leading academic medical center and to advance excellence in patient care, education, and research that improves health in North Philadelphia and beyond.” 

As President and CEO of Temple University Hospital and its campuses—Main Campus, Jeanes Campus, Episcopal Campus, Temple Women & Families Hospital and Temple Health–Chestnut Hill Hospital—Mr. Rastogi has guided the institution to national prominence for quality, innovation, and clinical excellence. Temple University Hospital has become a destination of choice for complex, specialized care, with the Temple Lung Center now recognized as the nation’s highest volume lung transplant program. Mr. Rastogi has also delivered more than $100 million in annual impact through operational and financial improvements and has played a pivotal role in the success of Temple Health–Chestnut Hill Hospital and the launch of the Temple Women & Families Hospital. In his [23]-year tenure, Rastogi has worked with or within nearly every part of Temple Health, helping to advance patient services and clinical infrastructure, and expanding Temple’s capacity to reinvest in mission-driven priorities.  

Read more about the leadership transition at Temple Health here.